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REVUE DE LA LITTÉRATURE / LITERATURE REVIEW

Chirurgie orale / Oral Surgery

INTRAMUSCULAR VERSUS SUBMUCOSAL
DEXAMETHASONE INJECTION IN SURGICAL
EXTRACTION OF IMPACTED MANDIBULAR THIRD
MOLARS: A NARRATIVE REVIEW
Mohammad Sleiman *

Abstract
The aim of this narrative review is to compare the results of different studies concerning the intramuscular route versus the submucosal route for injection
of dexamethasone in cases of surgical extraction of mandibular impacted third molars. The advantages and disadvantages of the different techniques will
be reported. Studies discussed in this paper revealed that the submucosal route featured so many benefits over the intramuscular one by being simple,
comfortable, highly bioavailable, painless, less risky and able to reduce trismus.
Keywords: Corticosteroids – dexamethasone – submucosal – intramuscular - third molar surgery.
IAJD 2020;11(1):51-55.

INJECTION INTRAMUSCULAIRE VERSUS SOUS-MUQUEUSE
DE DEXAMETHASONE DANS L'EXTRACTION CHIRURGICALE DE
TROISIEMES MOLAIRES MANDIBULAIRES INCLUSES: REVUE
NARRATIVE
Résumé
L’objectif de cette revue narrative est de comparer les résultats de différentes études concernant la l’injection intramusculaire par rapport à l’injection
sous-muqueuse pour l’administration de dexaméthasone dans les cas d’extraction chirurgicale de troisièmes molaires incluses. Les avantages et les
inconvénients des différentes techniques ont été décrites. Les études présentées dans cet article ont révélé que la voie sous-muqueuse présentait de
nombreux avantages par rapport à la voie intramusculaire; elle est simple, confortable, hautement biodisponible, non douloureuse, moins risquée et
capable de réduire le trismus.
Mots-clés: corticostéroïdes - dexaméthasone – injection sous-muqueuse - intramusculaire - troisième molaire.
IAJD 2020;11(1):51-55.
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Introduction
Surgical extraction of an impacted wisdom tooth may lead to several
challenges one of which include postoperative complications and morbidity characterized mainly by pain and
swelling.
When removing an impacted wisdom tooth, some traumatic procedures are necessary including flap, the
removal of bone (guttering), sectioning
of the tooth; all of which may result in
considerable amount of pain, swelling,
edema and trismus since the region of
surgery is mostly composed of loose
connective tissue that contains blood
and lymph vessels [1].
These complications can be
controlled by managing the inflammatory process associated with the
surgical procedure through different
methods. The use of corticosteroids
injection is considered as one of these
methods because they are anti-inflammatory agents [2].
Corticosteroids are a class of
chemicals that includes two types;
either natural steroid hormones that
are produced in the adrenal cortex
of vertebrates or the synthetic analogues of these hormones. The corticosteroids are classified according
to their duration of action. The shortacting glucocorticoids include cortisol (hydrocortisone) and cortisone,
with duration of action less than 12
hours and anti-inflammatory potency
of 1 day. Intermediate acting glucocorticoids have duration of action of
12–36 hours. They include prednisone
and prednisolone with anti-inflammatory potency of 4, and 6-methylprednisolone and triamcinolone, both
having anti-inflammatory potency of 5.
Dexamethasone and betamethasone
are long-acting glucocorticoids, with
duration of action greater than 36 h
and anti-inflammatory potency of 25h
[3].
Mechanism of action
These agents act by inhibiting
the body’s inflammatory response to
injury through various mechanisms,

with a reduction of fluid transudation
and therefore edema. They inhibit both
the cyclo-oxygenase pathways chemotaxis by starting the production of lipocortin 1, which inhibits phospholipase
A. All this cycle leads to a decrease in
the synthesis of prostaglandins and
leukotrines. These corticosteroids
suppress the immune system by reducing the immunoglobulin and complement concentrations and affecting the
antigen- antibody binding [1].
Dexamethasone
Since a considerable time, dexamethasone (Fig. 1) has been used
widely in the sector of oral and maxillofacial surgery to decrease post-operative surgical morbidity for having
the least adverse effects on leukocyte
chemotaxis [4, 5]. Furthermore, dexamethasone is one of the most potent
anti-inflammatory drugs and for this
reason it has been used following
minor oral surgery [6].
The normal hormonal effects associated with prolonged steroid therapy
are essentially absent with a single
injection. If undesirable hormonal
effects do occur, they are reversible
and disappear when the steroid is discontinued [7].
Dexamethasone is contraindicated in the conditions of diabetes mellitus, peptic ulcers, active or healed
tuberculosis, hypertension, ocular
herpes, glaucoma, acute and chronic
infections, osteoporosis, Cushing’s
syndrome, and renal insufficiency.
Furthermore, the use of dexamethasone is contraindicated in case of
pregnancy.
Different methods exist for the
administration of dexamethasone. One
of these is the intramuscular injection
method. Other methods include the
submucosal injection methods [10].
Intramuscular dexamethasone
injection
Few are those studies who have
objectively discussed the effect of
dexamethasone given through an
intramuscular injection (Fig. 2) in
third molar surgery [11]. That is des-

Fig. 1: Dexamethasone structure.

Fig. 2: Intramuscular injection of
dexamethasone.

pite the fact that this route is the most
familiar one when a steroid injection
is prescribed in outpatients. Studies
revealed that intramuscular route for
administering dexamethasone can
be effective if a single dose is given
either preoperatively or postoperatively [5]. Different studies reported
variable results concerning the use of
this route for third molar surgery [7];
this technique’s effect could be dosedependent. Some authors suggested
using dexamethasone 8–12 mg for
optimum results [12, 15].
In a study by Majid et al. [11],
intramuscular dexamethasone lead
to signiﬁcant reduction in swelling
on the first and third postoperative
days besides signiﬁcant reduction in
pain scores, but had no notable effect
on trismus in comparison with the
controls. This suggests the effectiveness of this route of administration
to decrease postoperative swelling
and pain after third molar surgery. The
result of this study confirmed previous
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Fig. 3: Submucosal injection of
dexamethasone.

study results concerning the effectiveness of this route to administer dexamethasone after wisdom tooth surgery
[7, 13-15].
Furthermore, a study by Klongnoi
et al. [16] revealed that a single-dose
intramuscular injection of dexamethasone can decrease postoperative facial
pain and swelling without having an
effect on trismus following the surgical
extraction of a lower impacted third
molar.
Submucosal dexamethasone
injection
To
administer
dexamethsone
through the submucosal route, the
needle of the syringe should be directed into the buccal vestibule close to
the site of surgery (Fig. 3).
The submucosal injection is a
way of administering dexamethasone
orally in cases of surgical removal of
impacted third molars. Many studies
confirmed the efficiency of this technique to deliver this type of corticosteroid locally into the surgical site and
to decrease the postoperative morbidity. Several studies will be reviewed
concerning that efficiency.
A study done by Nair et al. [17]
to evaluate submucosal injection of
intraoperative dexamethasone (4mg)
to decrease postoperative discomfort
after third molar surgery resulted in
a comparable or greater reduction of
postoperative edema in cases where
submucosal route was used instead
of other routes of administration. The

study suggested that the submucosal
route offers a higher effective drug
concentration at the surgical site without loss due to distribution to other
compartments as in intramuscular
injection. Furthermore, the submucosal route is considered convenient for
both the surgeon and the patient.
Another study by Ehsan et al. [18]
affirmed that the submucosal route for
injection of dexamethasone is considered a reliable technique for reducing
postoperative swelling and trismus following third molar surgeries.
A third study by Moraschini et al.
[19] suggested that the submucosal
injection of dexamethasone presents
a reduction in the postoperative symptoms and signs resulting from surgical
extraction of impacted third molars,
mainly those associated with edema
and pain.
Warraich et al. [20] concluded in
their study about submucosal dexamethasone injection in relation to postoperative discomfort following third
molar surgery that patients receiving
dexamethasone showed a significant
reduction in pain, swelling, trismus,
a tendency to less neurological complaints and improved quality of life.
A systematic review and meta-analysis done by Chen et al. [21] discussed
the effect of submucosal injection of
dexamethasone on edema, trismus,
and pain during early and late postoperative periods after surgical extraction of third molars. The study suggested that submucosal injection of
dexamethasone successfully reduced
not only early and late edema but also
early trismus in experimental compared with control participants after wisdom teeth extraction, which makes it a
good choice for dental clinical use.
An additional study by Grossi et al.
[22] was concerned about the effectiveness of submucosal injection of dexamethasone after third molar surgery,
besides comparing the efficacy of 4 mg
versus 8mg dose of this corticosteroid.
Results suggested that the use of dexamethasone 4 mg, given as an intraoral
injection (submucosal) at the time of
surgery, is effective in the prevention

of postoperative edema. Increasing
the dose to 8 mg provides no further
benefit.
Submucosal dexamethasone versus
intramuscular dexamethasone
Many studies were concerned
about comparing submucosal route
and intramuscular route for injecting
dexamethasone. Comparable results
obtained reveal that submucosal dexamethasone is a powerful alternative
to dexamethasone that is given systemically (intramuscular) [11]. The
intramuscular route is characterized by
patient’s discomfort and the need for
speciﬁc tools to give the drug; these
factors may limit the use of the intramuscular route [23].
Submucosal injection of dexamethasone 4 mg was found to be
an effective therapeutic strategy for
boosting the quality of life after surgical removal of impacted lower third
molars with a similar effect on postoperative morbidity in comparison to
intramuscular injection [11].
Furthermore, the rate of absorption
is highly dependent on the blood ﬂow
to the site [24]. This suggests that a
higher absorption and effect of dexamethasone can take place if it is given
locally (submucosal). Moreover, injecting submucosal dexamethasone is
considered a quite simple procedure,
conservative (low invasiveness), suitable for the surgeon and the patient,
and offers a low priced solution for
the typical discomfort associated with
the extraction of impacted lower third
molars [11]. Dexamethasone given
through submucosal injection has the
advantage of being concentrated at the
surgical area and thus has less systemic absorption and no further manipulation of the tissues.
Concerning
this
comparison
between the two routes of administration, another study was carried by
Sabhlok et al. [25].This study revealed that the oral route is considered
superior in comparison to the intramuscular route when administering
dexamethasone in cases of surgical
removal of mandibular third molars,
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Route of
injection

Intramuscular
route

Submucosal
route

Site

Efficiency

Extraoral
(systemic)

Effective to a
certain extent

Local
(intraoral)
(Less systemic absorption of the
drug)

-better efficacy
(high drug
concentration at
the surgical site)
-high
bioavailability

Pain

Dose required

Painful

8mg

Less or
no pain

4mg (half
dose of the
intramuscular)
(less systemic
absorption of the
drug)

Trismus
relieving

Technique

Timing

No

Traumatic and
not comfortable for the
patient

Postoperative

Yes

Simple, less
invasive, and
comfortable
for the dentist
and the patient

Preoperative or
postoperative

Table 1: Comparison between intramuscular and submucosal routes of dexamethasone injection in surgical extraction of mandibular third molars.

with respect to bio-availability, drug
dosage, and resolution of trismus [25].

issue following the surgical extraction
of mandibular impacted third molars.

Discussion

Conclusion

All these discussed studies revealed many advantages of submucosal
route for injection of dexamethasone
over the intramuscular route. Both
techniques are effective in reducing
pain and edema into similar extents;
however, the submucosal technique is
considered more reliable. The submucosal route is characterized by having
an effective drug concentration at the
surgical site and thus a better bioavailability, and as a result, a better efficacy. Besides, injecting submucosal
dexamethasone is a quite simple procedure with less or no pain in comparison to the intramuscular one. In addition to that, it is more comfortable for
the dentist and the patient. Moreover,
this technique is given locally around
the surgical site and not systemically
as the intramuscular one requiring
also a less drug dosage (4mg instead of
8mg), and these two features decrease
the systemic absorption of the drug
and reduce the risk for systemic side
effects. One more important benefit of
submucosal technique over the intramuscular one is its ability to relieve
trismus which is considered a critical

Submucosal dexamethasone route
of injection (oral) should be preferred
over the intramuscular dexamethasone one (systemic) in surgical extraction of mandibular third molars since
they are similarly effective in reducing
pain and edema as the intramuscular
one, and featuring more advantages
which include being simple, comfortable, highly bioavailable, painless,
less risky , and able to reduce trismus.
To be effective, the required dose of
submucosal dexamethasone is 4mg
instead of 8mg where there is no difference in efficacy between the two
doses. Additional studies concerning
the timing of injection (preoperative,
intraoperative, or postoperative) must
be carried to figure out the proper
timing of dexamethasone injection for
best medical benefits.
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